IRTC

In a report released today, Allen Gong from J.P. Morgan maintained a Buy rating on Irhythm Technologies (IRTC - Research Report), with a price target of $186.00. The company's shares closed yesterday at $126.77.Gong covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Beauty Health, and NuVasive. According to TipRanks, Gong has an average return of -4.3% and a 40.00% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Irhythm Technologies with a $160.71 average price target, implying a 26.77% upside from current levels.
https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-buy-rating-on-irhythm-technologies-irtc?utm_source=advfn.com&utm_medium=referral